HKSE · 8372.HK
Grand Brilliance Group Holdings Limited
HK$0.17+HK$0.00 (+0.61%)
Grand Brilliance Group Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 7.78% below the high.
Loading market information…
HKSE · 2135.HK · HKD
Stock price, earnings
Quote as of Oct 30, 2026, 03:53 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Raily Aesthetic Medicine International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Raily Aesthetic Medicine International Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Raily Aesthetic Medicine International Holdings Limited is an investment holding company primarily engaged in providing a comprehensive range of cosmetic medical services. Its operations are structured into three principal segments: Aesthetic Medical Services, Consulting Services, and the distribution of Aesthetic Medical Equipment Products. The company's service offerings include various aesthetic procedures such as: Surgical interventions: encompassing cosmetic surgeries performed on different areas of the face or body. Minimally invasive treatments: largely consisting of aesthetic injection procedures. Aesthetic dermatology: featuring diverse energy-based treatments. Aesthetic dental care: including orthodontic services, dental implants, and teeth whitening. Management consulting: providing specialized advisory services for aesthetic medical practices. Furthermore, Raily trades in medical equipment and sells surgical implants alongside aesthetic medical skincare products. The company manages and operates a network of four private, for-profit aesthetic medical clinics located in China's Zhejiang and Anhui Provinces. It serves a diverse clientele, including individual retail customers and other aesthetic medical institutions. Founded in 2008 and headquartered in Hangzhou, People's Republic of China, Raily Aesthetic Medicine International Holdings Limited operates as a subsidiary of Ruide Consultation Limited.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:51 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$0.17+HK$0.00 (+0.61%)
Grand Brilliance Group Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 7.78% below the high.
HK$0.21+HK$0.01 (+5.5%)
Republic Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 24.64% below the high.
HK$0.11+HK$0.01 (+7.92%)
Wanjia Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 47.85% below the high.
HK$0.19-HK$0.02 (-10.38%)
Kelfred Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 65.45% below the high.
HK$0.15-HK$0.00 (-0.65%)
Medicskin Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 24.0% below the high.
HK$0.32HK$0.00 (0.0%)
Qianhai Health Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 77.5% below the high.
HK$0.06-HK$0.00 (-1.61%)
Elegance Optical International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 64.12% below the high.
HK$0.02-HK$0.00 (-10.0%)
Pa Shun International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 77.5% below the high.
